Real-time enrollment status for this pulmonary hypertension due to lung disease (disorder) clinical trial
Current Status
Recruiting
Checked: August 30, 2026 at 1:55 PM UTC
| NCT Number | NCT07285655 |
| Recruiting Status | Recruiting |
| Condition | Pulmonary Hypertension Due to Lung Disease (Disorder) |
| Phase | PHASE3 |
| Target Enrollment | 344 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Liquidia Technologies, Inc. |
| Last Updated on CT.gov | June 29, 2026 (Jun 29, 2026) |
As of August 30, 2026: Clinical trial NCT07285655 is currently recruiting participants. This phase3 study for pulmonary hypertension due to lung disease (disorder) is actively seeking new participants at 5 locations across the United States. The study is sponsored by Liquidia Technologies, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07285655 is actively recruiting participants as of August 30, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07285655 was last updated Jun 29, 2026 (June 29, 2026). HelloStudys verifies this status automatically.